NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $976,847 | +122.5% | 60,523 | +472.2% | 0.00% | – |
| Q2 2023 | $438,937 | -37.9% | 10,578 | -9.9% | 0.00% | – |
| Q1 2023 | $706,450 | -63.6% | 11,744 | -55.6% | 0.00% | -100.0% |
| Q4 2022 | $1,939,187 | +130.4% | 26,445 | +19.4% | 0.00% | 0.0% |
| Q3 2022 | $841,841 | -6.7% | 22,148 | +70.7% | 0.00% | 0.0% |
| Q2 2022 | $902,000 | -23.3% | 12,974 | -8.6% | 0.00% | 0.0% |
| Q1 2022 | $1,176,000 | -22.5% | 14,196 | -29.8% | 0.00% | 0.0% |
| Q4 2021 | $1,518,000 | -76.8% | 20,233 | -64.1% | 0.00% | -66.7% |
| Q3 2021 | $6,548,000 | -0.7% | 56,367 | +89.5% | 0.00% | 0.0% |
| Q2 2021 | $6,597,000 | +1.3% | 29,742 | -39.6% | 0.00% | 0.0% |
| Q1 2021 | $6,511,000 | +571.9% | 49,261 | +777.5% | 0.00% | – |
| Q4 2020 | $969,000 | – | 5,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |